WO2010122407A3 - Hypolipaemic pharmaceutical compositions - Google Patents

Hypolipaemic pharmaceutical compositions Download PDF

Info

Publication number
WO2010122407A3
WO2010122407A3 PCT/IB2010/000898 IB2010000898W WO2010122407A3 WO 2010122407 A3 WO2010122407 A3 WO 2010122407A3 IB 2010000898 W IB2010000898 W IB 2010000898W WO 2010122407 A3 WO2010122407 A3 WO 2010122407A3
Authority
WO
WIPO (PCT)
Prior art keywords
hypolipaemic
pharmaceutical compositions
guggulsterones
dien
antagonist
Prior art date
Application number
PCT/IB2010/000898
Other languages
French (fr)
Other versions
WO2010122407A8 (en
WO2010122407A2 (en
Inventor
Indravadn Ambalal Modi
Bakulesh Mafatlal Khamar
Chhitar Mal Gupta
Anju Puri
Rabi Sankar Bhatta
Ram Pratap
Girish Kumar Jain
Smrati Bhadauria
Ashok Kumar Khanna
Omkar Prasad Asthana
Ashim Ghatak
Original Assignee
Cadila Pharmacueticals Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Pharmacueticals Ltd. filed Critical Cadila Pharmacueticals Ltd.
Publication of WO2010122407A2 publication Critical patent/WO2010122407A2/en
Publication of WO2010122407A3 publication Critical patent/WO2010122407A3/en
Publication of WO2010122407A8 publication Critical patent/WO2010122407A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril

Abstract

The present invention related to hypolipaemic pharmaceutical compositions comprising lipid lowering agents and BAR antagonist such as 3β-hydroxy pregna-5,16-dien-20-one (Herein known as 16 DP), Guggulsterones, 16 DP is also given a compound number 80/574.
PCT/IB2010/000898 2009-04-22 2010-04-21 Hypolipaemic pharmaceutical compositions WO2010122407A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1052/MUM/2009 2009-04-22
IN1052MU2009 2009-04-22

Publications (3)

Publication Number Publication Date
WO2010122407A2 WO2010122407A2 (en) 2010-10-28
WO2010122407A3 true WO2010122407A3 (en) 2011-03-03
WO2010122407A8 WO2010122407A8 (en) 2011-04-21

Family

ID=43011533

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2010/000898 WO2010122407A2 (en) 2009-04-22 2010-04-21 Hypolipaemic pharmaceutical compositions

Country Status (1)

Country Link
WO (1) WO2010122407A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060198906A1 (en) * 2005-03-07 2006-09-07 Sami Labs Limited Compositions and Method to Increase Serum Levels of HDL cholesterol and Lower the Risk of Cardiovascular Disease
US20070172468A1 (en) * 2006-01-25 2007-07-26 Reliv International Inc. Dietary supplements for reducing cholesterol levels
US20080139520A1 (en) * 2006-08-22 2008-06-12 Jain Mahendra K Altering cholesterol and fat uptake by novel allosteric inhibitors of pancreatic phospholipase A2

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060198906A1 (en) * 2005-03-07 2006-09-07 Sami Labs Limited Compositions and Method to Increase Serum Levels of HDL cholesterol and Lower the Risk of Cardiovascular Disease
US20070172468A1 (en) * 2006-01-25 2007-07-26 Reliv International Inc. Dietary supplements for reducing cholesterol levels
US20080139520A1 (en) * 2006-08-22 2008-06-12 Jain Mahendra K Altering cholesterol and fat uptake by novel allosteric inhibitors of pancreatic phospholipase A2

Also Published As

Publication number Publication date
WO2010122407A8 (en) 2011-04-21
WO2010122407A2 (en) 2010-10-28

Similar Documents

Publication Publication Date Title
UA94833C2 (en) Substituted bicyclolactams
WO2008083248A3 (en) Cyclopamine analogs
WO2007148185A3 (en) Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
WO2007112093A3 (en) Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
TW200728307A (en) Novel spirochromanone derivatives
WO2008013838A3 (en) Pyridizinone derivatives
WO2007135527A3 (en) Benzimidazolyl compounds
PT2310356E (en) Adamantyl diamide derivatives and uses of same
WO2008022286A3 (en) Small molecule inhibitors of kynurenine-3-monooxygenase
TN2013000253A1 (en) Bicyclo[3.2.1]octyl amide derivatives and uses of same
WO2008121348A3 (en) Peripheral opioid receptor antagonists and uses thereof
WO2011056511A3 (en) 4,6-diaminopyrimidine stimulators of soluble guanylate cyclase
WO2010018549A3 (en) Therapeutic compositions containing macitentan
WO2008059370A3 (en) Substituted bicyclocarboxyamide compounds
IL199891A (en) Aqueous compositions of (e)-2,4,6-trimethoxystyryl-3-carboxymethylamino-4-methoxybenzylsulfone for parenteral administration
WO2009055289A3 (en) Therapeutic substituted lactams
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
WO2008001201A3 (en) Pharmaceutical compositions of clopidogrel
WO2009124962A3 (en) Sulfonamides
UA104420C2 (en) Use of glutaric acid derivatives or the pharmaceutically acceptable salts thereof as anti-arrhythmic agents
WO2010077730A3 (en) Indanone inhibitors of acetylcholinesterase
TN2012000105A1 (en) Spirolactam derivatives and uses of same
WO2009102707A3 (en) Substituted oxazaphosphorines
MX2009008249A (en) Pharmaceutical composition comprising a campothecin derivative.
IL194094A0 (en) Stable pharmacuetical compositions of 2-aza-bicyclol[3.3.0]-octane-3-carboxylic acid derivatives

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10766716

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10766716

Country of ref document: EP

Kind code of ref document: A2